Valpak Clipp and Valvoline Instant Oil Change have partnered to launch their largest consumer sweepstakes ever, offering a chance to win a new vehicle worth over $40,000. The promotion runs through November 6, 2026, and is accessible via Valpak envelopes and Clipp magazines mailed to households nationwide. Entry is free and open to U.S. residents aged 18 and older, with the winner announced around November 9. This campaign aims to boost consumer engagement by combining both brands' reach and is supported by digital and social media efforts.
Valpak Clipp's largest consumer giveaway offers a new car worth over $40,000. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Sep 29, 2026 19:27 WIB: Out of 112 priced US stocks, 77 rose and 25 fell. Notable movers include KMX (CarMax, Inc) at USD 59.49 with a +5.20% change and 100% buy order activity, NIO Inc. at USD 3.47 down -3.34% with 81% sell order activity, and Aptiv PLC at USD 44.99 up +3.09%.
Precision Optics Corporation reported a strong Q4 with record revenue of $8.8 million, a 42% increase year-over-year, surpassing analyst estimates of $7.1 million. The company also beat EPS expectations, posting -$0.01 versus the predicted -$0.06, si...
Analyst firm Craig-Hallum adjusted Boot Barn Holdings' price target to $224, an 84.91% increase from its recent stock price of $121.14, reflecting strong growth potential. The company aims to expand merchandise margins by 60 basis points in fiscal 20...
Traders on prediction platforms Kalshi and Polymarket estimate a nearly 60% chance that the US added more than 90,000 jobs in September, with about a 50-50 chance of surpassing 100,000 jobs. This outlook is more optimistic than the Dow Jones economis...
GameStop's stock surged 31% in the past month, driven by CEO Ryan Cohen's significant personal share purchases, even as the overall gaming sector declined. While the VanEck Video Gaming and eSports ETF dropped 2%, and major peers like Take-Two Intera...
Inventiva announced improved financial results for the first half of 2026, reducing its net loss to €69.5 million from €175.9 million the previous year. The company completed the final patient visit in its Phase 3 NATiV3 trial for MASH, with topline ...
